These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26039231)

  • 21. Mood and personality-based models of substance use.
    Chakroun N; Johnson EI; Swendsen J
    Psychol Addict Behav; 2010 Mar; 24(1):129-36. PubMed ID: 20307120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse effects of stimulant drugs in a community sample of drug users.
    Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J
    Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress report from the testing program for stimulant and depressant drugs (1996).
    France CP; Gerak LR; Rowlett JK; Woolverton WL; Winger G; Woods JH
    NIDA Res Monogr; 1998 Mar; 178():429-39. PubMed ID: 9686406
    [No Abstract]   [Full Text] [Related]  

  • 24. Differentiation of personality types among opiate addicts.
    Blatt SJ; Berman WH
    J Pers Assess; 1990; 54(1-2):87-104. PubMed ID: 2313556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deliberate self-harm in substance-dependent patients and relationship with alexithymia and personality disorders: a case-control study.
    Verrocchio MC; Conti C; Fulcheri M
    J Biol Regul Homeost Agents; 2010; 24(4):461-9. PubMed ID: 21122286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Substance use risk personality trait for adolescents].
    Omiya S; Kobori O; Tomoto A; Igarashi Y; Iyo M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Dec; 47(6):287-97. PubMed ID: 23461217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired decision making in opiate addiction correlates with anxiety and self-directedness but not substance use parameters.
    Lemenager T; Richter A; Reinhard I; Gelbke J; Beckmann B; Heinrich M; Kniest A; Mann K; Hermann D
    J Addict Med; 2011 Sep; 5(3):203-13. PubMed ID: 21844835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Addiction and personality].
    Franques P; Auriacombe M; Tignol J
    Encephale; 2000; 26(1):68-78. PubMed ID: 10875064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The guinea-pig isolated atrium as a model system for the central actions of selected CNS stimulant and depressant drugs. Part 1: 3,3-Diakylglutarimide homologues and related drugs.
    Arblaster CI; Cameron DW; Lavi Y; Laycock GM; Shulman A
    Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):503-47. PubMed ID: 2891885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance-abusing schizophrenics: do they self-medicate?
    Goswami S; Mattoo SK; Basu D; Singh G
    Am J Addict; 2004; 13(2):139-50. PubMed ID: 15204665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. History of suicide attempt in male substance-dependent inpatients and relationship to borderline personality features, anger, hostility and aggression.
    Evren C; Cinar O; Evren B; Celik S
    Psychiatry Res; 2011 Nov; 190(1):126-31. PubMed ID: 21872941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What does self-identified drug of choice tell us about individuals under community corrections supervision?
    Clark BC; Perkins A; McCullumsmith CB; Islam AM; Sung J; Cropsey KL
    J Addict Med; 2012 Mar; 6(1):57-67. PubMed ID: 22227577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians.
    Lensing MB; Zeiner P; Sandvik L; Opjordsmoen S
    Atten Defic Hyperact Disord; 2013 Dec; 5(4):369-76. PubMed ID: 23975605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correspondence of the MMPI-2 and MCMI-II in male substance abusers.
    Ward LC
    J Pers Assess; 1995 Apr; 64(2):390-3. PubMed ID: 7722864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
    Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
    J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personality factors in human drug self-administration.
    Pickens RW; Heston LL
    NIDA Res Monogr; 1981 Jul; 37():45-62. PubMed ID: 6798467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exploration of group compassion-focused therapy for personality disorder.
    Lucre KM; Corten N
    Psychol Psychother; 2013 Dec; 86(4):387-400. PubMed ID: 24217864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reevaluating the self-medication hypothesis among the dually diagnosed.
    Henwood B; Padgett DK
    Am J Addict; 2007; 16(3):160-5. PubMed ID: 17612818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deliberate self-harm in nondepressed substance-dependent patients.
    Lavania S; Ram D; Praharaj SK; Khan AH; Pattojoshi A
    J Addict Med; 2012 Dec; 6(4):247-52. PubMed ID: 22895462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.